All
Patients With COVID-19 Treated for Cancer at Risk for Thromboembolisms
January 18th 2024Patients recently treated for cancer who required hospitalization for COVID-19 were at risk for venous thromboembolisms (VTEs), recent research has found, with investigators determining that patients who experience a thromboembolic event (TEE) are at a 20% to 25% risk of death.
Endocrine Therapy Effective Subsequent Advanced Breast Cancer Treatment
January 16th 2024Endocrine therapy, particularly when administered in combination with Verzenio (abemaciclib), is effective when compared with chemotherapy among patients with metastatic breast cancer who experienced disease progression on Ibrance (palbociclib), according to recently published research.